Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002
- 1 July 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 56 (3) , 846-853
- https://doi.org/10.1016/s0360-3016(03)00214-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Molecular assessment of lymph nodes in patients with resected stage I non–small cell lung cancer: Preliminary results of a prospective studyThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancersSeminars in Oncology, 2002
- High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosisHuman Mutation, 2001
- First-Line Herceptin® Monotherapy in Metastatic Breast CancerOncology, 2001
- Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell RadiosensitizationJNCI Journal of the National Cancer Institute, 2001
- The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for TherapyThe International Journal of Cell Cloning, 1998
- Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumorsJournal of Neuro-Oncology, 1997
- Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.Journal of Clinical Oncology, 1993
- Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervixBritish Journal of Cancer, 1993
- Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: Preliminary correlations with local control and overall survivalInternational Journal of Radiation Oncology*Biology*Physics, 1993